Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2025-03-14 Regulatory Filings
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence
Regulatory Filings Classification · 95% confidence The document is explicitly titled and formatted as a "Press Release" announcing the publication of a study ("New BRAVO Study Publication Reinforces Clinical Benefits of BLC..."). It details clinical trial results, quotes executives and authors, and provides links to the full publication and an editorial. This structure—a formal announcement of new information, often related to research or financial performance, distributed via press release—most closely aligns with an Earnings Release (ER) if it contained financial results, or a Regulatory Filing (RNS) if it were a general regulatory update. Since this is a specific announcement about clinical data publication, and it is not a full financial report (10-K, IR) or a presentation (IP), it fits best under the general regulatory/announcement category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a press release announcing scientific/clinical news that doesn't fit a more specific financial or corporate governance category. It is not an ER because it focuses on clinical data, not period financial results.
2025-03-14 English
Photocure ASA – Major shareholding disclosure
Major Shareholding Notification Classification · 98% confidence The document is titled 'Photocure ASA – Major shareholding disclosure' and explicitly states that a party (Briarwood Chase Management LLC) now controls 20.17% of the company's outstanding share capital and voting rights. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The filing type code for this is MRQ.
2025-02-28 English
NOTIFICATION OF MAJOR HOLDINGS
Major Shareholding Notification Classification · 100% confidence The document is explicitly titled "Standard form for notification of major holdings." This form details changes in share ownership thresholds crossed by an entity (SEB Investment Management) in an issuer (Photocure ASA). This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of a Major Shareholding Notification. The key indicators are: 1. Title: "NOTIFICATION OF MAJOR HOLDINGS". 2. Content: Reporting the percentage of voting rights held (4.10% resulting situation vs. 5.31% previous) and the date the threshold was crossed (2025-02-28). 3. This matches the definition for Major Shareholding Notification (Code: MRQ).
2025-02-28 English
NOTIFICATION OF MAJOR HOLDINGS
Major Shareholding Notification Classification · 99% confidence The document text explicitly states "NOTIFICATION OF MAJOR HOLDINGS" and directs the user to an attachment on 'www.newsweb.no'. This strongly indicates a notification regarding significant share ownership changes. Based on the definitions, the code 'MRQ' (Major Shareholding Notification) is the most appropriate classification. Given the extremely short length (107 characters) and the instruction to 'Please see attachment', it could potentially be an RPA, but the content is a direct notification type, making MRQ more specific and accurate for the subject matter.
2025-02-28 English
Photocure ASA: Results for the fourth quarter of 2024
Investor Presentation Classification · 99% confidence The document explicitly states 'Highlights for fourth quarter 2024 and post-period news' and presents detailed financial tables comparing Q4 2024 results with Q4 2023, along with full-year (FY 2024 vs FY 2023) comparisons. It includes key performance indicators like revenue, EBITDA, and management commentary on the period's performance. This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often preceding the more comprehensive Quarterly Report (IR). Since it focuses on the 'Highlights' and the CEO's commentary on the period's results, ER is the most appropriate classification over IR (which is typically more comprehensive) or 10-K (which is annual).
2025-02-19 English
Photocure ASA: Results for the fourth quarter of 2024
Investor Presentation Classification · 99% confidence The document is explicitly titled "Photocure ASA 4th Quarter and Full Year 2024 Results" and contains detailed financial highlights, strategic priorities, segment trends, and consolidated income statements for the fourth quarter and full year 2024. The content structure, including slides covering Q4 highlights, financial performance (Revenue, EBITDA), and strategic outlook, strongly indicates a presentation accompanying periodic financial results. Since it is a presentation summarizing quarterly and annual results, it aligns best with an Investor Presentation (IP) or potentially an Earnings Release (ER) if it were just the press release. Given the detailed slide format and the disclaimer referencing the annual report, this is classified as an Investor Presentation.
2025-02-19 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.